Last reviewed · How we verify
TEV-53408
At a glance
| Generic name | TEV-53408 |
|---|---|
| Sponsor | Teva Branded Pharmaceutical Products R&D LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease (PHASE2)
- A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TEV-53408 CI brief — competitive landscape report
- TEV-53408 updates RSS · CI watch RSS
- Teva Branded Pharmaceutical Products R&D LLC portfolio CI